Corporate Governance
Our Governance Compliance
People
See all
Academy
Omnia Academia
Careers
Open Jobs

Omnia Technologies expands its Life Sciences division

Tecnomaco will enhance Omnia Technologies’ global presence, service capabilities and portfolio of technological solutions

Omnia Technologies has completed the acquisition of Tecnomaco.

 

Founded in 1994 in Aprilia (Latina, Italy), Tecnomaco is a leading company in the segment of Pharma Packaging Machines, designing and manufacturing machines for counting, blistering, liquid filling and capping, powder dosing, labeling, printing and weight-checking. Thanks to its consolidated experience in the segment, it provides complete packaging lines for pharmaceutical, nutraceutical and cosmetic industries.

Today, the company has over 80 employees and an installed base of more than 1,000 machines and production lines across 90 countries.

 

Tecnomaco will strengthen Omnia Technologies Life Sciences’ division, which combines the expertise of top specialist in automation technologies for the pharmaceutical, cosmetic and diagnostic industry and other high quality historical brands such as Comas, Giuseppe Desirò and TecnoTrend.

 

“The acquisition of Tecnomaco significantly enhances Omnia Technologies’ portfolio of technological and automated solutions for the pharmaceutical industry, strengthening our service offering to customers globally” stated Andrea Stolfa, CEO of Omnia Technologies.

“With our Life Sciences division we strive to pioneer agility in services and machinery for Pharma, Cosmetics and Diagnostic: a brand-new concept and approach to the life sciences space to empower our brands’ specific know-how, supporting them with our global infrastructure”.

 

Carlo Federici, founder and CEO of Tecnomaco, who will continue to lead the company inside Omnia Technologies, commented: “I am very proud of the results achieved by Tecnomaco over the last 30 years. Together with our people, we have decided to join Omnia Technologies – a strong industrial partner – because we share the same values and have a common vision and belief that together we can accelerate the growth of Tecnomaco and Omnia Technologies Life Sciences’ division on a global scale.

 

Omnia Technologies was created by independently-managed investment subsidiaries of Investindustrial, a leading European investment firm, in November 2020 through the combination of Della Toffola, Bertolaso, TMCI Padovan, ACMI and the addition of several other strategic and complementary businesses. Following this acquisition, Omnia Technologies generates a consolidated turnover of over €726 million, with 36 production sites, 24 commercial offices and more than 2,400 employees.

 

Omnia Technologies was advised by Intesa Sanpaolo (IMI Corporate & Investment Banking Division).